Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02804022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia

Study acronym: VPIAmorphine
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Dec 31, 2025 to Dec 31, 2027v12
  2. Study completion date: Dec 31, 2024 to Dec 31, 2025v11
  3. Study completion date: Dec 31, 2022 to Dec 31, 2024v10
  4. Study completion date: Dec 31, 2021 to Dec 31, 2022v9
  5. Study completion date: Mar 31, 2021 to Dec 31, 2021v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study completion date: Aug 31, 2020 to Mar 31, 2021v7
  2. Start date: Jun 2016 to Dec 29, 2016
    • Primary completion date: Nov 2017 to May 30, 2017
    • Study completion date: Dec 2019 to Aug 31, 2020
    v6
  3. Trial status: Completed to Active, Not Recruiting
    • Study completion date: Dec 2017 to Dec 2019
    • Eligibility criteria expanded, about 4 words
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Recruiting to Completed
    • Primary completion date changed from estimate of Jun 2018 to Nov 2017
    • Study completion date changed from estimate of Jun 2018 to Dec 2017
    • Site details revised
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Interventions: VPIA analgesia (Device) to Morphine (Drug), VPIA analgesia (Device)
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a closed-loop system which is embodied in a novel and intelligent algorithm that takes into account patients' vital signs. The system allows better and responsive titration of personalized pain relief together with non-invasive physiological monitoring that measures oxygenation, breathing and heart rate continuously.
Trial Details
NCT Number NCT02804022
Lead Sponsor KK Women's and Children's Hospital
Conditions
(from sponsor)		 Respiratory Depression
Related terms Respiratory Insufficiency
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov